Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01769599

Enrollment

Registered

2013-01-16

Start date

2013-01-31

Completion date

2014-04-30

Last updated

2013-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Macular Edema, Diabetus Mellitus

Brief summary

there is no yet agreement about the best way to treat Diabetic Macular Edema (DME) the two options up to day are using Grid laser treatment Vs. Avastin injections or a combination of both in this study we want to compare the two attitudes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Diabetic patients with macular edema * age 30 to 80 Yrs. old * no previous ocular treatment * patiens with macular edema that was shown by OCT or FA * patients with at least 6 months follow-up after the last treatment

Exclusion criteria

* patients with other ocular disease (such as glaucoma etc.) * patients with previous ocular surgery * patiens with eye trauma * patiens with macular edema not from DM

Design outcomes

Primary

Measure	Time frame	Description
Macular thickness	36 months	by measuring the retinal thickness and comparing in both aproaches. and see if there is any difference.

Countries

Israel

Contacts

Primary ContactJoseph Pikkel, M.D

pikel.y@ziv.health.gov.il+972-50-4348206

Outcome results